Skip Navigation Links
Sinopharm (1099.HK)
12 Oct 2021 (674 views)  

Someone asked how he can invest in Sinopharm. 

So, I made this research. 

Sinopharm can be bought from the Hong Kong Stock Exchange. Its symbol is 1099.HK.

It has a historical PE ratio of 7.53 times and a forward PE ratio of 6.87 times. This implies that is profit for next year will grow by 9.6%.

Its dividend yield is 4%.

Its market capitalization is HK$ 65 billion ($11.3 billion SGD). It is a large company.

Its long term debt to equity is 21% (which is low), but its total debt to equity is 121% (which seems rather high).

The current stock price is $20.5 which is midway between the high and low for the past 52 weeks.

This stock meets my benchmark, so I may invest in it.

Additional comment.
Sinopharm's vaccine uses an inactivated virus.
However, they are now active in research to develop a mNRA vaccine.
They should be able to get it out soon. 
Article.


Tan Kin Lian

Note - I am giving a personal view. I am not giving investment advice. 

 


Sinopharm (1099.HK)
[Back] [Print]


Someone asked how he can invest in Sinopharm. 

So, I made this research. 

Sinopharm can be bought from the Hong Kong Stock Exchange. Its symbol is 1099.HK.

It has a historical PE ratio of 7.53 times and a forward PE ratio of 6.87 times. This implies that is profit for next year will grow by 9.6%.

Its dividend yield is 4%.

Its market capitalization is HK$ 65 billion ($11.3 billion SGD). It is a large company.

Its long term debt to equity is 21% (which is low), but its total debt to equity is 121% (which seems rather high).

The current stock price is $20.5 which is midway between the high and low for the past 52 weeks.

This stock meets my benchmark, so I may invest in it.

Additional comment.
Sinopharm's vaccine uses an inactivated virus.
However, they are now active in research to develop a mNRA vaccine.
They should be able to get it out soon. 
Article.


Tan Kin Lian

Note - I am giving a personal view. I am not giving investment advice.